Entrada Therapeutics, Inc. (TRDA) Balance Sheet
As of 2026-06-30 (10-Q), Entrada Therapeutics, Inc. (TRDA) reported total assets of $298.9M, total liabilities of $65.5M and shareholders' equity of $233.4M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $99.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TRDAEntrada Therapeutics, Inc.Follow TRDA — free
—
Price chart with a free account
- Market cap
- 171.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 291.1 | 45.2 | 67.6 | 101.2 | 90.4 | 99.3 | |
| Short-term investments | 0.0 | — | — | — | — | — | |
| Current assets | 298.7 | 209.9 | 369.8 | 440.0 | 306.3 | 232.7 | |
| Total assets | 305.8 | 252.1 | 469.2 | 526.3 | 377.4 | 298.9 | |
| Current liabilities | 6.7 | 22.0 | 158.8 | 39.5 | 24.5 | 21.4 | |
| Total liabilities | 7.1 | 39.5 | 226.8 | 97.6 | 71.2 | 65.5 | |
| Shareholders' equity | 298.7 | 212.6 | 242.4 | 428.7 | 306.1 | 233.4 |
USD millions · SEC XBRL
Entrada Therapeutics, Inc. — questions
- How much cash does Entrada Therapeutics, Inc. have?
- $99.3M in cash and cash equivalents as of 2026-06-30.
- What are Entrada Therapeutics, Inc.'s total assets?
- $298.9M as of 2026-06-30.
- What is Entrada Therapeutics, Inc.'s shareholders' equity?
- $233.4M as of 2026-06-30.
Every figure on this page comes from Entrada Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.